Tumor Response after Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Comparison of Diffusion-weighted Functional MR Imaging with Anatomic MR Imaging

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 8, 2008, Pages 1180-1186

  Rhee, Thomas K ^a   Naik, Neel K ^a   Deng, Jie ^a,b   Atassi, Bassel ^a   Mulcahy, Mary F ^a   Kulik, Laura M ^a   Ryu, Robert K ^a   Miller, Frank H ^a   Larson, Andrew C ^a,b   Salem, Riad ^a   Omary, Reed A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; YTTRIUM 90;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIODIAGNOSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT DURATION; TUMOR VOLUME;

BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; DIFFUSION MAGNETIC RESONANCE IMAGING; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; PROGNOSIS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 48949115246     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.05.002     Document Type: Article

References (37)

1. Kew M.C. Epidemiology of hepatocellular carcinoma. Toxicology (2002) 35-38 181182.
2. Chow D.H., Sinn L.H., Ng K.K., et al. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study. J Surg Oncol 94 (2006) 565-571
3. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
4. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
5. Lau W.Y., Leung W.T., Ho S., et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70 (1994) 994-999
6. Salem R., Lewandowski R., Roberts C., et al. Use of yttrium-90 glass microspheres (Therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15 (2004) 335-345
7. Goin J.E., Salem R., Carr B.I., et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16 (2005) 205-213
8. Murthy R., Xiong H., Nunez R., et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16 (2005) 937-945
9. Salem R., Lewandowski R.J., Atassi B., et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (Therasphere): safety, tumor response, and survival. J Vasc Interv Radiol 16 (2005) 1627-1639
10. Kamel I.R., and Bluemke D.A. Imaging evaluation of hepatocellular carcinoma. J Vasc Interv Radiol 13 suppl (2002) S173-S184
11. De Santis M., Alborino S., Tartoni P.L., Torricelli P., Casolo A., and Romagnoli R. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 7 (1997) 10-16
12. Kuszyk B.S., Boitnott J.K., Choti M.A., et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology 217 (2000) 477-486
13. Namimoto T., Yamashita Y., Sumi S., Tang Y., and Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 204 (1997) 739-744
14. Taouli B., Vilgrain V., Dumont E., Daire J.L., Fan B., and Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226 (2003) 71-78
15. Chan J.H., Tsui E.Y., Luk S.H., et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 26 (2001) 161-165
16. Deng J., Rhee T.K., Sato K.T., et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 41 (2006) 410-414
17. Moffat B.A., Chenevert T.L., Lawrence T.S., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102 (2005) 5524-5529
18. Theilmann R.J., Borders R., Trouard T.P., et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6 (2004) 831-837
19. Kamel I.R., Bluemke D.A., Ramsey D., et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 181 (2003) 708-710
20. Chen C.Y., Li C.W., Kuo Y.T., et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and mr diffusion constants-initial experience. Radiology 239 (2006) 448-456
21. Kamel I.R., Bluemke D.A., Eng J., et al. The role of functional mr imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 17 (2006) 505-512
22. Buijs M., Kamel I.R., Vossen J.A., Georgiades C.S., Hong K., and Geschwind J.F. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol 18 (2007) 957-963
23. Deng J., Miller F.H., Rhee T.K., et al. Diffusion-weighted mr imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 17 (2006) 1195-1200
24. Kamel I.R., Reyes D.K., Liapi E., Bluemke D.A., and Geschwind J.F. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 18 (2007) 49-56
25. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
26. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
27. Mardor Y., Pfeffer R., Spiegelmann R., et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high B-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21 (2003) 1094-1100
28. Hein P.A., Eskey C.J., Dunn J.F., and Hug E.B. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 25 (2004) 201-209
29. Pickles M.D., Gibbs P., Lowry M., and Turnbull L.W. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24 (2006) 843-847
30. Einarsdottir H., Karlsson M., Wejde J., and Bauer H.C. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol 14 (2004) 959-963
31. Ichikawa T., Haradome H., Hachiya J., Nitatori T., and Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170 (1998) 397-402
32. Kim T., Murakami T., Takahashi S., Hori M., Tsuda K., and Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 173 (1999) 393-398
33. Sun X.J., Quan X.Y., Huang F.H., and Xu Y.K. Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J Gastroenterol 11 (2005) 6535-6537
34. Eom Y.W., Kim M.A., Park S.S., et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24 (2005) 4765-4777
35. Verheij M., and Bartelink H. Radiation-induced apoptosis. Cell Tissue Res 301 (2000) 133-142
36. Roninson I.B., Broude E.V., and Chang B.D. If not apoptosis, then what?. Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Update 4 (2001) 303-313
37. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization For Research And Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216